Bluebird Spins Off Oncology Business As Cell, Gene Therapy Segments Grow Apart

Gene Therapy Focus Opens Partnering, Acquisition Opportunities

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.